Experience

Davis Polk advised the representatives of the several underwriters in connection with the $296 million SEC-registered offering of 9,545,000 shares of common stock of 1Life Healthcare,…

Davis Polk advised BRP Group, Inc. on its $175.2 million follow-on offering of 13,225,000 shares of Class A common stock, which includes 1,725,000 shares from the full exercise of the…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered offering by Intuit Inc. of $500 million aggregate principal amount of 0.650% notes due 2023, …

Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the $69 million follow-on offering of common stock of Magenta Therapeutics…

Davis Polk advised The Royal Bank of Scotland Group plc, a public limited company incorporated under the laws of Scotland, in connection with its SEC-registered shelf takedown of $1.5…

Davis Polk advised the joint book-running managers and the initial purchasers in Rule 144A/Regulation S offerings of €325 million principal amount of 2.750% senior secured notes due 2028…

We won complete dismissal of the matter

Davis Polk advised the joint book-running managers in connection with an SEC-registered offering by Xylem Inc. of $500 million aggregate principal amount of its 1.950% senior notes due…

Davis Polk advised the sole book-running manager in connection with the $215.6 million common stock offering of 6,900,000 shares of common stock of Editas Medicine, Inc. The common…

Davis Polk advised Exxon Mobil Corporation on the SEC-registered offering of €1.5 billion principal amount of 0.142% notes due 2024, €1 billion principal amount of 0.524% notes due 2028, €1…